Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Net Cash Flow (2021 - 2025)

Core Scientific (CORZW) has disclosed Net Cash Flow for 5 consecutive years, with -$142.1 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 124.36% to -$142.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$525.6 million through Dec 2025, down 168.5% year-over-year, with the annual reading at -$525.6 million for FY2025, 168.5% down from the prior year.
  • Net Cash Flow hit -$142.1 million in Q4 2025 for Core Scientific, down from -$127.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $583.2 million in Q4 2024 to a low of -$142.1 million in Q4 2025.
  • Historically, Net Cash Flow has averaged $15.1 million across 5 years, with a median of $6.6 million in 2023.
  • Biggest five-year swings in Net Cash Flow: surged 10014.08% in 2024 and later tumbled 583.59% in 2025.
  • Year by year, Net Cash Flow stood at -$28.3 million in 2021, then skyrocketed by 151.52% to $14.6 million in 2022, then crashed by 60.5% to $5.8 million in 2023, then soared by 10014.08% to $583.2 million in 2024, then tumbled by 124.36% to -$142.1 million in 2025.
  • Business Quant data shows Net Cash Flow for CORZW at -$142.1 million in Q4 2025, -$127.9 million in Q3 2025, and -$117.4 million in Q2 2025.